Moleculera Biosciences Press Releases

• Published on October 30, 2024 - 12:15 GMT

  

  Moleculera Biosciences Awarded $500K Grant to Clinically Validate Immune-mediated Cardiovascular Disorder Biomarkers

  Precision medicine blood panel to aid in diagnosing and treating patients with myocarditis, cardiomyopathy, and chronic heart failure due to immune dysfunction OKLAHOMA CITY, OK, UNITED STATES, October 30, 2024 /⁨EINPresswire.com⁩/ -- Moleculera …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on September 10, 2024 - 12:00 GMT

  

  Moleculera Biosciences welcomes Asad Hussain as Board Advisor on Strategic Finance

  Appointment will help company drive financial performance, enhance operational efficiencies, and support long-term growth objectives OKLAHOMA CITY, OK, UNITED STATES, September 10, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, a precision medicine …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on August 22, 2024 - 12:00 GMT

  

  Moleculera Biosciences Names B. Robert Mozayeni, MD as Medical and Clinical Advisor

  Appointment will provide strategic guidance and insights as the company expands scope of work for immune-mediated disorders OKLAHOMA CITY, OK, USA, August 22, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company focused …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on July 30, 2024 - 12:15 GMT

  

  Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors

  Rebrand aligns with precision medicine messaging for growth and expansion into additional immune-mediated disorder markets OKLAHOMA CITY, OK, USA, July 30, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, a precision medicine company focused on uncovering …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on July 10, 2024 - 12:00 GMT

  

  Moleculera Biosciences Names Dr. Safedin Sajo Beqaj as Clinical Laboratory Advisor

  Appointment strengthens Company's Scientific and Clinical Board of Advisors as it continues to expand scope of its personalized medicine business OKLAHOMA CITY, OK, USA, July 10, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on May 23, 2024 - 14:15 GMT

  

  Moleculera Biosciences Board of Directors names Healthcare Innovator and Leader Dr. Vijay Aggarwal as Board Chair

  OKLAHOMA CITY, OK, UNITED STATES, May 23, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Biosciences, Inc., a precision medicine company focused on identifying and directing treatment for immune-mediated CNS and cardiovascular disorders, has appointed long-time …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on January 17, 2024 - 13:15 GMT

  

  Moleculera Labs Forms Strategic Collaboration with Quest Diagnostics

  Companies Collaborate to Broaden Access to Moleculera's Novel Neuropsychiatric Autoantibody Testing OKLAHOMA CITY, OKLAHOMA, UNITED STATES, January 17, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc, a precision medicine company pioneering immune- …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on January 11, 2024 - 13:15 GMT

  

  Moleculera Labs, Inc., Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm

  Company leveraging strategic alliance w/OKC-based General Genomics to build next-gen predictive treatment model for immune-mediated neuropsychiatric disorders OKLAHOMA CITY, OK, UNITED STATES, January 11, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on January 3, 2024 - 13:00 GMT

  

  Moleculera Labs Names Healthcare Industry Veteran Rodney Cotton to Board of Directors

  Company readies for growth and expansion of its business to identify and improve chronic immune-mediated disorders OKLAHOMA CITY, OKLAHOMA, UNITED STATES, January 3, 2024 /⁨EINPresswire.com⁩/ -- Moleculera Labs, Inc., an Oklahoma City-based personalized …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...